Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Panbela Therapeutics
AddedFeb 20, 2024
UpdatedJun 18, 2026
Panbela Therapeutics

Panbela Therapeutics

Public

Panbela Therapeutics: A biopharmaceutical firm specializing in pancreatic cancer treatments.

HQ
Waconia, MN, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to develop innovative treatments for pancreatic cancer, Panbela Therapeutics is a biopharmaceutical company dedicated to improving patient outcomes in oncology. The company's core vision is to advance the science of cancer treatment through rigorous research and development. Panbela's primary product offerings include therapeutics specifically designed for pancreatic cancer, with a focus on novel drug combinations that enhance efficacy and safety. Their market focus is on addressing the unmet medical needs of cancer patients globally.

Notable achievements for Panbela Therapeutics include the issuance of new patents in the US and Canada for a fixed-dose combination of eflornithine and sulindac, which underscores their commitment to innovation. The company has also garnered attention through presentations at prominent medical conferences such as Digestive Disease Week (DDW). With a strong foundation of scientific expertise and strategic partnerships, Panbela continues to make significant strides in the biopharmaceutical industry, aiming to transform the landscape of cancer treatment and improve patient survival rates.

Panbela Therapeutics - Similar Companies

Panacela Labs logo

Panacela Labs

panacelalabs.com

Panacea Pharmaceuticals logo

Panacea Pharmaceuticals

PanTher Therapeutics logo

PanTher Therapeutics

panthertx.com

PNP Therapeutics logo

PNP Therapeutics

Traws Pharma logo

Traws Pharma

Palm Therapeutics logo

Palm Therapeutics

Puma Biotechnology logo

Puma Biotechnology

Saladax Biomedical logo

Saladax Biomedical

Pelican Therapeutics logo

Pelican Therapeutics

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Ascenta Therapeutics logo

Ascenta Therapeutics

G1 Therapeutics logo

G1 Therapeutics

g1therapeutics.com

PanTheryx logo

PanTheryx

pantheryx.com

Pinnacle Biologics logo

Pinnacle Biologics

PellePharm logo

PellePharm

pellepharm.com

Panbela Therapeutics - Quick Facts

Who are Panbela Therapeutics' competitors?

Companies similar to Panbela Therapeutics include Panacela Labs, Panacea Pharmaceuticals, PanTher Therapeutics and PNP Therapeutics.

When was Panbela Therapeutics founded?

Panbela Therapeutics was founded in 2011.

Where is Panbela Therapeutics' headquarters located?

Panbela Therapeutics' headquarters is located in Waconia, MN, US.

When was Panbela Therapeutics' last funding round?

Panbela Therapeutics' most recent funding round was for $9M (USD) in January 2024.

How much has Panbela Therapeutics raised to-date?

As of Jan 29, 2024, Panbela Therapeutics has raised a total of $64.4M (USD).

How many employees does Panbela Therapeutics have?

Panbela Therapeutics has 5 employees as of Feb 6, 2024.

Panbela Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Oncology Treatments
Tags
  • Biotech
  • Financial
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 22 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 541500Computer Systems Design and Related Services
  • 541512Computer Systems Design Services
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 541510Computer Systems Design and Related Services
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 7373Computer Integrated Systems Design
  • 4000Railroad Transportation
  • 6000Depository Institutions
  • 7300Business Services
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 6202Computer consultancy and computer facilities management activities